Purchases and Sales Made in Q4 2021 in Igm Biosciences, Inc. (IGMS)
This table provides information about the institutional ownership of Igm Biosciences, Inc. (IGMS) during Q4 2021. The information is specifically focused on institutions that hold shares of IGM Biosciences, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Feb 14, 2022
Q4 2021
|
Ikarian Capital, LLC
Dallas, TX |
SELL
|
- |
-50K- 97.09% |
$1.38M - $3.32M
|
1.5K
$9.77K
|
|
|
Feb 14, 2022
Q4 2021
|
Redmile Group, LLC
San Francisco, CA |
SELL
|
- |
-91.1K- 2.66% |
$2.51M - $6.05M
|
3.33M
$21.7M
|
|
|
Feb 11, 2022
Q4 2021
|
Ensign Peak Advisors, Inc
Salt Lake City, UT |
SELL
|
- |
-149K- 76.04% |
$4.1M - $9.87M
|
46.9K
$305K
|
|
|
Feb 14, 2022
Q4 2021
|
Woodline Partners LP
San Francisco, CA |
SELL
|
- |
-166K- 29.1% |
$4.57M - $11M
|
403K
$2.63M
|